BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34098555)

  • 61. Burden of kidney disease on the discrepancy between reasons for hospital admission and death: An observational cohort study.
    Mandai S; Ando F; Mori T; Susa K; Iimori S; Naito S; Sohara E; Uchida S; Fushimi K; Rai T
    PLoS One; 2021; 16(11):e0258846. PubMed ID: 34731197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease].
    Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypertension in Patients Hospitalized with COVID-19 in Wuhan, China.
    Zhang Y; Sha T; Wu F; Hu H; Chen Z; Li H; Han J; Song W; Huang Q; Zeng Z
    Int Heart J; 2021 Mar; 62(2):337-343. PubMed ID: 33678794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative analysis between the use of renin-angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection.
    Martínez-Del Río J; Piqueras-Flores J; Nieto-Sandoval Martín de la Sierra P; Negreira-Caamaño M; Águila-Gordo D; Mateo-Gómez C; Salas-Bravo D; Rodríguez-Martínez M
    Med Clin (Barc); 2020 Dec; 155(11):473-481. PubMed ID: 32782110
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
    Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
    J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.
    Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y
    Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and Radiologic Characteristics of COVID-19 in Patients With CKD.
    Abrishami A; Khalili N; Dalili N; Khaleghnejad Tabari R; Farjad R; Samavat S; Neyriz Naghadehi A; Haghighatkhah H; Nafar M; Sanei-Taheri M
    Iran J Kidney Dis; 2020 Jul; 14(4):267-277. PubMed ID: 32655021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection.
    Aghaaliakbari F; Abbasi MA; Ranjbar M; Jamshidi Makiani M; Farrokhpour M; Safarnezhad Tameshkel F; Karbalaie Niya MH; Doltkhah S; Yaghoobzadeh K; Savaj S
    Iran J Kidney Dis; 2020 Dec; 14(6):482-487. PubMed ID: 33277453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Short- and long-term survival of patients hospitalized for COVID-19 in relation to cardiovascular risk factors and established cardiovascular disease: the Cor-Cardio study.
    Ostrowska A; Prejbisz A; Dobrowolski P; Wojciechowska W; Rajzer M; Terlecki M; Krzanowski M; Grodzicki T; Hryniewiecki T; Dąbrowski R; Kreutz R; Januszewicz A;
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36826715
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.
    Becerra-Muñoz VM; Núñez-Gil IJ; Eid CM; García Aguado M; Romero R; Huang J; Mulet A; Ugo F; Rametta F; Liebetrau C; Aparisi A; Fernández-Rozas I; Viana-Llamas MC; Feltes G; Pepe M; Moreno-Rondón LA; Cerrato E; Raposeiras-Roubín S; Alfonso E; Carrero-Fernández A; Buzón-Martín L; Abumayyaleh M; Gonzalez A; Fernández Ortiz A; Macaya C; Estrada V; Fernández-Pérez C; Gómez-Doblas JJ
    Age Ageing; 2021 Feb; 50(2):326-334. PubMed ID: 33201181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 in Grade 4-5 Chronic Kidney Disease Patients.
    Collado S; Arenas MD; Barbosa F; Cao H; Montero MM; Villar-García J; Barrios C; Rodríguez E; Sans L; Sierra A; Pérez-Sáez MJ; Redondo-Pachón D; Coca A; Maiques JM; Güerri-Fernández R; Horcajada JP; Crespo M; Pascual J
    Kidney Blood Press Res; 2020; 45(5):768-774. PubMed ID: 32898845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nondipping heart rate and associated factors in patients with chronic kidney disease.
    Biyik Z; Yavuz YC; Altintepe L; Celik G; Guney I; Oktar SF
    Clin Exp Nephrol; 2019 Nov; 23(11):1298-1305. PubMed ID: 31482253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Gnavi R; Demaria M; Picariello R; Dalmasso M; Ricceri F; Costa G
    Clin Infect Dis; 2020 Nov; 71(16):2291-2293. PubMed ID: 32442294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.
    Jung SY; Choi JC; You SH; Kim WY
    Clin Infect Dis; 2020 Nov; 71(16):2121-2128. PubMed ID: 32442285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical characteristics, outcomes and risk factors for mortality in hospitalized diabetes and chronic kidney disease patients after COVID-19 infection following widespread vaccination.
    Zou Y; Qin C; Yang Q; Lang Y; Liu K; Yang F; Li X; Zhao Y; Zheng T; Wang M; Shi R; Yang W; Zhou Y; Chen L; Liu F
    J Endocrinol Invest; 2024 Mar; 47(3):619-631. PubMed ID: 37725309
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis.
    Puicón-Suárez JB; Zeña-Ñañez S; Failoc-Rojas VE
    PeerJ; 2022; 10():e13437. PubMed ID: 35722260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study.
    Karadag S; Ozturk S; Arici M; Gorgulu N; Akcali E; Pembegul I; Taymez DG; Kazancioglu R; Ayar Y; Mutluay R; Ozdemir A; Aydin Z; Bashan Y; Alagoz S; Yilmaz F; Trabulus S; Dirim AB; Ozturk I; Inci A; Azak A; Aktas N; Kuzu T; Dheir H; Basturk T; Ozler TE; Dincer MT; Turgutalp K; Ulu S; Gungor O; Bakir EA; Odabas AR; Seyahi N; Yildiz A; Ates K
    Int Urol Nephrol; 2023 Feb; 55(2):399-408. PubMed ID: 35951255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.